THROMBOTIC MICROANGIOPATHY
Clinical trials for THROMBOTIC MICROANGIOPATHY explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC MICROANGIOPATHY trials appear
Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common drug tested as lifesaver for dangerous transplant side effect
Disease control OngoingThis study is testing whether N-acetylcysteine (NAC), a safe and affordable drug, can treat a severe and potentially fatal blood vessel complication that can happen after a stem cell transplant. It will enroll 44 adult patients who have developed this condition, called TA-TMA, to…
Matched conditions: THROMBOTIC MICROANGIOPATHY
Phase: PHASE2, PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug tested to combat deadly transplant complication
Disease control OngoingThis study is testing whether the drug ravulizumab can help control a dangerous blood clotting and organ damage condition (TMA) that sometimes occurs after a stem cell transplant. It will compare the drug plus standard care against a placebo plus standard care in about 148 partic…
Matched conditions: THROMBOTIC MICROANGIOPATHY
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC